Search Reports :

Booming Biotech Market in India

Share |
Publish Date:  Apr, 2010 No. of Pages: 110
Format: Adobe Reader (PDF) Upto 24 hour delivery
Booming Biotech Market in India
  Electronic Access - Single User License   US$ 1400.00
  CD-ROM Mail Delivery   US$ 1600.00
  Hard Copy Mail Delivery   US$ 1600.00
  Electronic Access - Multi-User License   US$ 2000.00
Description
Table of Content List of Figures & Tables

Thanks to a large pool of scientific talent, world-class information technology industry, and vibrant pharmaceutical sector, the Indian biotech industry has stupendously grown over the past few years. During FY 2005-FY 2009, the industry witnessed an impressive CAGR of around 26.5% and generated total revenue of INR 121.4 Billion (US$ 2.4 Billion) in FY 2009. Moreover, the industry has been able to survive successfully amid the global financial turmoil. Government initiatives, like set up of more biotech parks and encouragement to public-private-partnerships, provided cushion to the biotech industry against tough economic conditions of recession.

According to our new research report “Booming Biotech Market in India”, the year-on-year growth of the biotech market is expected to accelerate in near future on the back of high demand for vaccines, CROs, biopesticides, biofertilizers, biodiesel and biotherapeutics in India as well as at the global level. In this regard, we have done an extensive research and analysis of the biotech market together with its segments.

Our research has found that the biopharma segment constitutes a major part of the total biotech market. It has experienced consistent rise in revenue and the trend is likely to continue in future as well. Talking about future outlook of the overall biotech market, it will remain buoyant despite the recent economic downturn. The baseline for optimistic future projection of the market is pouring of investments to promote research and support entrepreneurship in the emerging segments. Besides, cutting edge research in globally emerging segments (such as contract bio-manufacturing services, clinical development services, etc) and developing in-house capability to manufacture innovative biopharma products will also pave the way for the Indian biotech market over the forecast period (FY 2011- FY 2013).

Our report provides comprehensive information, rational analysis and reliable statistics of the biotech market in India. The report has thoroughly examined current market trends, industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years. Due consideration has been given to the possible aftereffects of recession on the industry while making the report.

Not able to find data you are looking for? Ask our Research Analyst.

All Research Reports

- Healthcare Industry (51)

   - Pharma (16)

   - Biotech (7)

   - Healthcare (20)

   - Vaccine (2)

   - Generics (6)

 

Related Reports

- Indian Biotechnology Mark...
- Indian Biotech Industry (...
- Asia Pacific Biotechnolog...
- US Biotech Market Analysi...
- Emerging Biotech Sector i...
 
Related Research News
May 03, 2010
Apr 30, 2010
Apr 05, 2010
Jan 25, 2010
Related Press Releases
Jul 15, 2010
Jun 23, 2010
May 05, 2010
Mar 29, 2010
Email Subscription
Receive email alerts of new market research report in your industry.

Check out our latest reports on What’s New page.
Not able to find the data you are looking for?
Consider requesting a
Custom Research Proposal.
Home | About Us | Careers | Request a Quote | Discounted Reports | Contact Us | Resources | Add URL | FAQ
Copyright © 2010, RNCOS, 2002-2010
Phone : +91 (120) 4224700/01/02/03 Fax : +91 (120) 4224707